In the last 5 years, FDA has actively characterized innovative ECG analysis methods for proarrhythmia assessments in clinical trials. ECG is a cornerstone of cardiac safety monitoring in toxicology and safety pharmacology with similarities between clinical and non-clinical evaluations.

A presentation was given by CitoxLab North America during SOT Annual Meeting & ToxExpo 2019, in Baltimore:

Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Line

April 6-9, 2019
Orlando, Florida – USA
Booth #916

Join the 12 000 scientists that will participate to EB annual meeting and visit our booth to learn more about our latest developments.

This year, we will focus on isolated organs & tissues studies with:

Wire myograph systems

• Suitable for the study of microvessels
• Designed for routine use by lab technicians and students
• Ideal for cardiovascular & gastrointestinal disease studies

NEW emkaMYO2:
Manually driven and equipped with 1 or 2 myograph modules. Learn more.

Tissue baths systems

• Suitable for the study of tissue strips and vessels
• emkaBATH2: manually driven, compact, easy to use
• emkaBATH4: fully automated, ability to switch from tubular to microvessel baths 

Perfusion systems

• Designed for research on liver, kidney or mesenteric bed function
• Ideal for studies of kidney diseases, liver fibrosis, Hepatotoxicity

NEW  Learn more.

Isolated Heart systems

• Suitable for mice and rats Langendorff or Working Hearts studies
• Ideal for safety assessment for IND-enabling studies

How to find us?

April 12-14, 2019
Tokyo – JAPAN
Booth#46

Join us at the 59th Annual Meeting of the Japanese Respiratory Society (JRS) in Tokyo. The program promises three days of interesting sessions, including:

• Update on pathogenesis in COPD
• Recent Advances in ARDS
• Lung injury and repair in pulmonary fibrosis
• Pathobiology in pulmonary hypertension
• Sleep apnea

COPD, ARDS, pulmonary fibrosis, pulmonary hypertension and sleep apnea are just some of the research areas where the flexiVent and the plethysmographs has been proven to be the gold standard for in vivo lung function measurement.

We look forward to talks, poster sessions and new collaboration opportunities that will emerge from this meeting.

We hope to see you in Tokyo!

emka TECHNOLOGIES will be exhibiting at the 92nd Annual Meeting of the Japanese Pharmacological Society. This year, the theme is “Concerto on science and innovation toward new horizon of pharmacology “.

Join experts in life science and drug discovery science to discuss collaborations and to attend special lectures and sessions. This will be an opportunity to learn more about emka  solutions for your pharmacological studies:

• Monitoring physiological data from conscious freely moving large animals using easyTEL+ implantable telemetry systems. Different models are available to meet your study needs, providing monitoring of ECG, EEG, blood pressure, breathing rate, temperature and acceleration from 3-axis accelerometer (activity).
• Non-invasive options for collecting ECG, blood pressure, breathing rate, temperature, and activity.
• Ex vivo studies of isolated organs and tissues 

Did you know? Our latest developments on implantable telemetry now allow researchers to remotely set implants to active or sleep mode. Animal can be monitored during several days, with no human interaction!

Join us during SOT Annual Meeting in Baltimore MD, USA for our exhibitor hosted session with Citoxlab.

Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Lines.

In the last 5 years, FDA has actively characterized innovative ECG analysis methods for proarrhythmia assessments in clinical trials. ECG is a cornerstone of cardiac safety monitoring in toxicology and safety pharmacology with similarities between clinical and non-clinical evaluations.

The session will compare well established ECG analysis methods used in toxicology with novel strategies that may offer lower false positive rates. Critical success factors in the analysis of pre-clinical ECGs will also be discussed.

The ECG’s acquired during this study were collected by easyTEL+ L EEEETA implanted telemetry. 

WHEN:         March 12, 2018  /  12:00 – 13:00
WHERE:       SOT & ToxExpo 2019, Baltimore Convention Center / Meeting Room 337
SPEAKER:    Dr. Simon Authier – Deputy Chief Scientific Officer, Citoxlab North America

2019 SOT Annual Meeting & ToxExpo
March 10-14, 2019
Baltimore MD – USA
Booth 4109 & 4111

How to find us?

March 4-5, 2019
Bethesda, Maryland – USA

The TBI Research Symposium 2019 is a platform for scientists from local organizations to exchange data and ideas that will advance research and treatment of traumatic brain injury (TBI).

As one of just 6 exhibitors during this symposium, we look forward to show our solutions for Neuro and CNS Research with the focus on TBI.

Animal models of TBI help scientists to study structural damage and functional deficits induced by brain injuries. Several studies demonstrated that long-term functional and structural changes take place up to 1 year after TBI.

emka’s solutions for TBI studies allow short but also long-term acquisition of various physiological parameters (EEG, EMG, blood pressure, respiration, temperature, activity) with:

• Implanted & Non-invasive Telemetry
• Plethysmography
• EEG analysis

Visit the symposium website.

March 1-2, 2019
Tokyo, Japan
Booth #G

emka TECHNOLOGIES will be exhibiting at the 10th annual JSPS meeting. Join us to learn more about our solutions for your safety pharmacology studies:

• Physiological data acquisition and analysis, with GLP modules
• Conscious respiratory function measurements
• Wireless implanted telemetry for freely moving group-housed rodents and non-rodents

Did you know? Our latest developments on implantable telemetry now allow researchers to remotely set implants to active or sleep mode. Animal can be monitored during several days, with no human interaction!

Februrary 25–28, 2019
Stuttgart – Germany
Booth #21

Join us at the 4^th German Pharm-Tox Summit, a joint conference organized and held by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with the Association of Clinical Pharmacology (VKliPha) and the Association for Applied Human Pharmacology (AGAH).

Visit our booth  #21 to find out how emka TECHNOLOGIES can help you in your toxicology studies.

February 14, 2019
11:00 am, Eastern Standard Time (New York, GMT-05:00)

Speaker: Josh Burton, Vice President, emka TECHNOLOGIES

Overview: A review of novel software tools and features.

• Parallel processing for improved analysis speed
• Tools to run and manage large waveform libraries
• Subject specific QT correction
• Building composite numeric and logical tests for event detection
• Case studies

This webinar is hosted by the Safety Pharmacology Society.
Please note that a member login is required to see the webinar.
For Nonmembers: You can either become a SPS Member or register as a nonmember and pay a fee to participate. More details here.

January 24-25, 2019
Hannover, Germany

emka TECHNOLOGIES and SCIREQ will be present at the 18th Fraunhofer Seminar “Models of Lung Disease”, organized by Fraunhofer ITEM in cooperation with the German Center for Lung Research (DZL).

This workshop will be the place to discuss new developments in translational lung research.

Our team is especially looking forward to Dr. Otmar Schmid’s (Helmholtz Zentrum) novel approach of drug delivery with the flexiVent.

You can learn about his innovative research titled “Ventilator-assisted aerosolized drug delivery: implications for animal models of lung disease” on January 24, 2019 at 9:30am.

See the complete program here.